DOHA: Hamad Medical Corporation’s (HMC) Corporate Pharmacy Department has started a collaborative partnership with American Society of Health System Pharmacists (ASHP) to develop an internationally accredited pharmacy residency programme.
The partnership is a key part of Corporate Pharmacy Strategy 2015-2018 and supports HMC’s progression as an Academic Health System (AHS).
A society team visited HMC, provided consultative advice and held a workshop for pharmacy leaders and hospital CEOs.
The society represents pharmacists who serve as patient care providers in acute and ambulatory settings and has more than 40,000 members, including pharmacists, student pharmacists and pharmacy technicians. The visit allowed the society to share insights into the residency programme, which started this August and provide opportunity to speak to pharmacy staff, technicians and nurses across HMC hospitals.
“It was clear in our visit that HMC pharmacy staff are committed to providing safe and effective use of medications.
“The inclusion of an ASHP-accredited pharmacy residency programme will elevate pharmacy programmes and services to the highest level of excellence.
“This will be a significant accomplishment for HMC,” said Douglas Scheckelhoff, Vice- President, Practice Advancement, ASHP, and a member of the team.
Dr Moza Al Hail, Executive Director of Pharmacy, HMC, said the residency programme will prepare pharmacists for clinical practice by providing intensive exposure to a wide range of patients during 12-month residency.
“Pharmacy residency training has long been recognised as the premier mechanism for clinical and administrative training of pharmacists. A central theme of any pharmacy residency programme in an AHS is improvement of clinical services. We believe that together, we will provide an excellent, patient-focused, safe and effective evidence-based pharmacy service to each of our patients.”
The Peninsula
